FDA in 2020: COVID Vaccine and OTC Ranitidine Drugs
Wednesday, December 23, 2020 In addition to the incredible work of agency scientists and reviewers to get the first COVID-19 vaccines authorized for emergency use in December (as we covered in Part 2 of our year-end post), the Food and Drug Administration (FDA) has continued to make substantial progress on its non-COVID priorities as well. Continued Progress on Non-COVID Priorities… Besides the obvious scientific, technical, and regulatory work that FDA and other stakeholders ha...
United States Scott Gottlieb Office Of Non Office Of Inspector Research Manufacturers Of America Ph Drug Administration
Source: natlawreview.com